Huntington Study Group   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Rochester NY United States (1993)

Organization Overview

First Clinical Trial
2005
NCT00146211
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Huntington's Study Group | Huntington Study Group

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chorea (Phase 3)

Huntington Disease (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 12
  • # of Trial APIs: 10